Based on our expression profiling, we conclude that DNMT1 and DNMT3B are consistently overexpressed in MYC-driven T-ALL and Burkitt’s lymphoma cell lines, while DNMT3A is overexpressed in human T-ALL cell lines only. The gene discussed is DNMT3A; the disease is Burkitt lymphoma.